Genmab Holding to acquire assets of iDD biotech - MarketLine Financial Deals

Genmab Holding to acquire assets of iDD biotech

Genmab Holding to acquire assets of iDD biotech - MarketLine Financial Deals
Genmab Holding to acquire assets of iDD biotech
Published Mar 18, 2015
2 pages — Published Mar 18, 2015
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Genmab Holding B.V., a Netherlands-based subsidiary of Genmab A/S, has entered into an agreement to acquire the antibodies and related patents, and know-how from iDD biotech SAS,

  
Source:
Document ID
MA154501_150320
Country
Country
Country
Ticker
GEN=DK
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Genmab Holding to acquire assets of iDD biotech" Mar 18, 2015. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Genmab-Holding-to-acquire-assets-of-iDD-biotech-2052-109894>
  
APA:
MarketLine Financial Deals. (2015). Genmab Holding to acquire assets of iDD biotech Mar 18, 2015. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Genmab-Holding-to-acquire-assets-of-iDD-biotech-2052-109894>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.